First human tests begin for experimental diabetes pill
NCT ID NCT07234864
Summary
This early-stage study is testing a new oral medication called ZE63-0302 in people with type 2 diabetes. Researchers want to understand how safe the drug is, how the body processes it, and how it affects blood sugar levels. The study will involve 60 adults who will take either the experimental drug or a placebo for four weeks while researchers monitor their health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emeritus Research Camberwell
RECRUITINGMelbourne, Victoria, 3124, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Emeritus Research Sydney
RECRUITINGBotany, New South Wales, 2019, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Momentum Clinical Research Sunshine
NOT_YET_RECRUITINGMelbourne, Victoria, 3021, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Momentum Clinical Research Taringa
NOT_YET_RECRUITINGBrisbane, Queensland, 4068, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Republican Specialized Scientific and Prectical Medical Center of Endocrinology named after Academician Yo. Kh. Turakulov
RECRUITINGTashkent, Tashkent, 100125, Uzbekistan
Contact
Conditions
Explore the condition pages connected to this study.